water proton signal change, the effects of equilibrium transcytolemmal water exchange may be significant in the data and thus should be admitted in DCE-MRI pharmacokinetic modeling.
INTRODUCTION
The use of (Dynamic-Contrast-Enhanced) DCE-MRI to study prostate disease began almost 15 years ago (1) and has increased significantly since then. Recent reviews include (2) (3) (4) (5) : the Bonekamp, Macura paper (4) is particularly recommended. As a consequence of this effort, the indications for DCE-MRI prostate studies have been proliferating. Recent contributions include (6) (7) (8) (9) (10) (11) .
The vast majority of mathematical models used for quantitative DCE-MRI are variants of the nuclear medicine radiotracer pharmacokinetic paradigm (4): we refer to this as the standard model (SM). However, we have pointed out a fundamental problem in the SM (12) . For T 1 -weighted 1 H 2 O signals, the bases for DCE-MRI, "tracerization" carries the incorrect corollary that inter-compartmental water molecule exchange be assumed effectively infinitely fast throughout the course of the DCE-MRI acquisition -the fast-exchange-limit [FXL] MR condition. Though the contrast reagent (CR) plays the role of the tracer molecule, the MR signal comes from the water molecule and most water is in intracellular spaces inaccessible to CR. The classic tracer molecule is also the signal molecule: its compartmentalization is not encoded into the signal. However, the CR compartmentalization is intrinsic to the DCE-MRI 1 H 2 O signal because the water compartmentalization is intrinsic. Thus, there are two molecular probes, CR and H 2 O, inherent in DCE-MRI. The shutter-speed pharmacokinetic model (SSM) was developed to shift from the tracer paradigm by allowing finite inter-compartmental water exchange kinetics (12) (13) (14) (15) . Relieving the FXL constraint of the SM can lead to remarkable performance by the SSM. With an SSM DCE-MRI follow-up to mammography, it is now possible to contemplate elimination of most if not all of the more than 70% of breast biopsy procedures that yield negative pathology reports (13, 14, 16, 17) .
The SSM is a "homogeneous" model [as is the SM] (12): i.e., it assumes "well-mixed"
compartments. There is a family of more highly parameterized "inhomogeneous" models (12) that can describe data just as well as the SSM. However, for a given number of compartments, each is less parsimonious.
In this contribution, we explore aspects of the pharmacokinetic modeling of in vivo prostate DCE-MRI data. These include: relative parameter influence, acquisition exchange (shutter-speed effect) sensitivity, applicable exchange conditions, parameter uncertainty, parameter correlation, and parameter pertinence. These help explain the success and limitations of the SSM. It is not surprising that if one uses a relatively exchange-insensitive acquisition sequence, shutter-speed effects are small (18) . However, because they afford a greater signal to noise (S/N) ratio, most prostate DCE-MRI acquisitions reported in the literature produce data that are rather exchange-sensitive. And yet, all studies but one (19) have used SM analyses.
The single application of the SSM to prostate DCE-MRI so far reported (19) is quite encouraging. It shows trends very similar to those we see for breast malignancy. In a companion paper, we report our own preliminary experience comparing shutter-speed analyses of prostate DCE-MRI data with pathology analyses of biopsy core specimens (20) . Also as with breast cancer, SSM promises high specificity in distinguishing malignant from benign prostate tissue.
THEORY
Starting from the Bloch Equation for longitudinal relaxation, the 2 nd generation Shutter-Speed
Model (SSM2) calculates the temporal DCE-MRI signal (magnetization) change. It considers all 5 three water populations (sites) [blood, interstitium, and intracellular] and can be manipulated to provide insights into parameter influences (12) . The mathematical expression of the model is best made in matrix form (12) , Equation (1) , where: M  (M b , M o , M i ) T is the three-element
compartmental water magnetization vector, C represents the equilibrium (physiological steady-state)
, and X is the exchange matrix, Equation (2).
The quantities R 1b , R 1o , and R 1i are the intrinsic T 1 relaxation rate constants [≡ (T 1 ) 
is given (12) as Equation (4) 
,L )}, and is thus commonly used (13) . The subscripts S and L designate the components with the smaller and larger T 1,2 values, respectively. R 1S , R 1L and a S /(a S + a L ) can be expressed in terms of the intrinsic system parameters as in Equations (6) and (7) . The transverse relaxation factors, exp(-TE•R * 2S,L ), are often assumed
to be unity. Three 2SX conditions are characterized as follows:
(because a S → 0 [as determined by Eq. (7) 
MATERIALS AND METHODS

Patient Population
The study was approved by both the Portland VA Medical Center (PVAMC) and the Oregon the DCE-MRI acquisition. It was delivered in 5 to 10 s, at 3.0 mL/s, followed by a 20 mL saline flush. We measured the arterial input function (AIF) from a femoral artery within the FOV.
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An individual AIF time-course was measureable for each subject except one, due to severe motion during the DCE acquisition. A population-averaged AIF based on six subjects was used for this subject.
An array of external receive RF coils was used for this work. Although an endorectal receive coil provides excellent signal, it has the disadvantages of: 1) yielding a very small FOV -limited to the pelvic region very near the prostate gland -which a) hinders radiation planning, and b) inhibits experimental MR AIF measurement from a large blood vessel, 2) distorting the gland from its shape in the absence of the coil, which would be that presented for radiation, and 3) increasing patient discomfort [fasting (or enema) and mild sedation are often used]. Since a possible outcome of the SSM DCE-MRI prostate protocol may be to shift a fraction of therapy from prostatectomy to radiation treatment, we have employed the surface RF coil array. As we will see, it provides quite sufficient MR signal.
Prostate Biopsy and Pathology
Each subject underwent a standard ten core prostate biopsy procedure performed using (exclusively) ultrasound guidance, subsequent to the DCE-MRI acquisition. Pathology examinations of biopsy core specimen fragments revealed Gleason scores ranging from 6 to 8. No subject had a prostate biopsy prior to the research MRI.
DCE-MRI Analyses
An ROI boundary was manually drawn around an area in a DCE-MR image for each of the 13 subjects. Its location had been outlined on a T 2 -weighted image slice by a radiologist
(not involved in DCE-MRI data processing) using hypointensity and morphology criteria, and pathology laterality. The DCE-MRI analyses were then performed by a different researcher. analysis. The signature mismatch (temporally correlated residuals) of the FXL fitting is the same as we have previously reported for breast malignancy (13, 16, 21, 25 Fig. 1e . The maximum enhancement is not very different from that of the suspicious ROI (Fig. 1d ). The differences in the S/S pre time-courses for the suspicious (Fig. 1d) and NAG (Fig. 1e) ROIs are seen to be mainly in their shapes. Propitiously, the SSM is especially sensitive to this property (15) . Consequently, the (water exchange) effects in these DCE data decrease -the gray dashed curves are increasingly closer to the points, reflecting the decreasing SSM(FXR-a) -SM(FXL-c) parameter differences. This is exactly as predicted by shutter-speed theory (12) , and observed in breast DCE-MRI (13, 14, 16, 17, 21) .
DCE-MRI
Determining Parameter Influence
A strength of SSM2 is that it covers the entire range of DCE-MRI CR extravasation kinetics, from very leaky tumor (fast extravasation) to normal brain (almost no extravasation) tissues. In these different situations, the various pharmacokinetic parameters may have drastically different influences on the tissue DCE-MRI time-courses (12,23).
Parameter influence (sensitivity) can be understood from simulations using SSM2. It is best that the most influential parameters be identified (or even ranked) prior to pharmacokinetic model fitting. The simplest way to do this is to generate a time-course based on fixed parameter values.
We illustrate this concept in Figure 2 for a case with small K trans magnitude. The AIF used for this 13 simulation (Fig. 1f inset) was determined from the ROI marked in Fig. 1c , and is shown in Fig. 2a . water exchange and blood volume fraction can be similar. As expected (13), relative parameter influences will also depend on the MRI acquisition pulse sequence parameters in addition to the acquisition window. Figure 3b shows the analog of Fig. 3a except that the read pulse flip angle is decreased from 15 to 8. The relative influences of the two exchange parameters,  b and  i , are seen to be increased. We will consider this below. Such analyses, based on SSM2, provide valuable insight into DCE-MRI experimentation, including the optimization of DCE-MRI pulse sequence parameters.
The Influence of τ i
The parameter analysis suggests that  i could be influential in prostate DCE-MRI pharmacokinetic modeling. Given its crucial role in breast cancer detection (13, 14, 16, 21) , and its important ability to measure cell membrane ion pumping activity (27) , τ i is a highly desirable new imaging biomarker. Since this water exchange measure is not one of the two most influential quantities, parameter interdependences might hinder its direct extraction. However, disproportionate signal quenching due to transverse relaxation may enhance the influence of τ i (13, 14) . This is not considered in the simplest SSM2 or in Figs For each, a new random noise (Gaussian distribution about zero) contribution was added to each Fig.   1d time-course data point. This was done so that each simulated time-course had a smaller S/N (roughly equal to that from a single voxel) than the actual ROI data (Fig. 1d points) and that the simulated data carry no bias from a potential model. Randomly generated initial guess K trans , v e , and (in two cases) τ i , values (28) were used for each fitting of each of the 400 simulated time courses. If the R 1S term was contributing proportionately ["reporting," Eqs. (5)- (7)], fitting the same data with SXR-a would be expected to change the returned τ i and K trans values only slightly from the FXR-a magnitudes (13) . However as we see, K trans reverts back to 0.26 (± 0.01), closer to its FXL-c value, the value of v e returned is 0.37 (± 0.002), and τ i rises to 40 s, the upper bound set for the iterative fitting algorithm (note the ordinate scale break): it is "pegged." Once again, the oval is a 1D bar. We have observed this behavior also for in vivo human malignant breast tumor (13, 14) and myocardial muscle (28) contribution can be evident (27, 29) .] On the other hand, the FXR-a returned value of τ i , 400 ms, is quite reasonable (12, 13) . Furthermore, FXR-a often yields a better match to the experimental time-course (Figs. 1d, 1e, and 1f) . Thus, we will henceforth demonstrate the capabilities of FXR-a as a practical tool for prostate DCE-MRI data. In effect, we are using the τ i magnitude as a model selection criterion.
Parameter Correlations and Uncertainties
Besides model and data agreement from a fitting, it is important to estimate any correlation between parameters varied, and also the parameter uncertainty resulting from the fitting process itself. To these ends, Monte Carlo simulations similar to those of Fig. 4 were carried out. These were applied to the data points of each of the three Fig. 1 time-courses (Figs. 1d, 1e , and 1f).
The Analogous to what we find for breast tumors (13, 14, 16, 17, 21) The drastically different parameter values for these tissue types from pharmacokinetic analyses that differ only in their water exchange kinetics assumptions exhibit mostly the effects of that exchange, which are unique to DCE-MRI pharmacokinetics.
Two Parameter Fittings
For tissues with low CR extravasation, the interstitial [CR] may not reach a level that transcytolemmal water exchange appears to slow significantly (12, 15) , and thus a three parameter FXR-a fitting carries larger uncertainty with little benefit (18) . However, a two parameter SSM(FXR-a) fitting with τ i held fixed, but at some reasonable nonzero value, can be beneficial when S/N is small. For the obturator muscle ROI, however, τ i is not as readily accessible (i.e., greater uncertainty).
The results in Fig. 7 suggest that for the three tissue ROIs chosen for this subject, τ i is ~450 ms, ~250 ms, and ~ 750 ms for the suspicious and normal-appearing prostate tissues and the obturator muscle tissue, respectively. The latter is similar to values we have reported for other muscle tissues (25) . It is important to note that for the smallest K trans value, that of the muscle ROI, the  i minimum "washes out" toward the FXL side, i.e.,  i  0. Thus, the  i value becomes less determinate, and approaches zero, not because  i is actually small [it is ~750 ms], but because K trans is small.
τ i Mapping
All of the results above are for ROI-averaged signal data. When the S/N is sufficient, one can apply analyses to signals on a pixel-by-pixel basis, and produce DCE-MRI parametric maps (13) (14) (15) (16) 21, 23) . values that are uniformly above the color scale maximum (which is the same as for Fig. 8a ). When the color scale maximum is raised considerably (Fig. 8c, for slice 9) , we see that SXR-a returns peripheral zone  i values overwhelmingly approaching the upper bound set for the iterative fitting, 40 s. This is just as unreasonable for this non-malignant prostate tissue as it is for the malignant tissue ROI analyzed in Fig. 4 . These  i values are pegged. Though there is spatial correlation in the (essentially binary) Fig. 8c map, it is not reasonable that all PZ τ i values be identical. That is, one does not expect a correct map to be binary. This spatial correlation further supports that the SXR-a incompatibility with the data is due to selective signal quenching rather than to some complicated parameter correlation. In conclusion, Figs. 4 and 8 each strongly indicates the incompatibility of the SXR-a model with prostate DCE-MRI data.
DISCUSSION
Extensive effort has been devoted to developing prostate DCE-MRI through the last decade We have shown that, due to the heavy CR extravasation, τ i can often be readily mapped using the FXR-a SSM approximation. We find this parameter to be elevated in the peripheral zone (PZ), where most cancers are found: there, τ i is often in the range of hundreds of ms, most influential to DCE-MRI pharmacokinetic modeling. Furthermore, the "cold" centers in the It is interesting to note that prostate glandular duct spaces are particularly abundant in the peripheral zone (11) . It is thought that, in the normal prostate, these spaces may be inaccessible to CR (11, 30) . If so, then the ductules will appear to the model as a fractional population of larger cells.
Though this might affect v e , it might particularly increase  i in the normal PZ (as we do see); if the duct spaces are larger than the parenchymal cells (11) . However, the ductules are lined with epithelial cells, and there could also be active cycling of water across the epithelium (27, 31) , which would prevent  i from being too large. It is thought that, in advanced cancer CR can enter the duct (11, 30) . This might be expected to make PZ v e and  i smaller in malignant foci. Perhaps the decreased tumor core  i observed in our SSM parametric mapping (20) 
